Why Neuropathy Medications Don’t Heal Nerve Damage — They Just Mask It

Almost every peripheral neuropathy patient who walks through our door has already been on a version of the same medication rotation: gabapentin, Lyrica (pregabalin), Cymbalta (duloxetine), or some combination of the three. That’s the standard first response from primary care doctors, neurologists, and pain specialists, and for many patients, it’s the only option they’ve ever been offered.
We want to be upfront about something important: these medications have a real, legitimate role in helping patients manage pain, and we never tell a patient to stop taking a prescribed medication. That decision belongs to you and your prescribing doctor. What we do think patients deserve to know is what these medications are actually doing — and, just as importantly, what they aren’t.
What These Medications Actually Do
Gabapentin and Lyrica work by calming overactive nerve signals — essentially turning down the volume on pain messages traveling to the brain. Cymbalta works differently, as an antidepressant (SNRI) that also affects how the brain processes pain signals.
All three can genuinely reduce how much pain a patient feels day to day. That relief matters, and we don’t discount it.
But none of these medications repair the underlying nerve damage that’s causing the pain and numbness in the first place. Peripheral neuropathy is, at its core, a problem of damaged and degenerating nerve tissue. Turning down the pain signal doesn’t stop that degeneration — it runs quietly in the background, whether or not a patient can feel it. This is why so many patients, like Mary in our companion post, find that their PN keeps advancing even while they’re faithfully taking their prescribed medications: the pain is being managed, but the nerves themselves are still declining.
Common Side Effects Patients Should Know About
Every medication involves tradeoffs, and these are no exception. This isn’t a complete list, and it isn’t medical advice — always review your specific situation with your prescribing doctor or pharmacist — but here’s a general overview of what’s commonly reported:
- Gabapentin: drowsiness, dizziness, fatigue, coordination problems, swelling in the hands or feet, and weight gain. Combined with opioids or other sedating medications, it can increase the risk of dangerous respiratory depression.
- Lyrica (pregabalin): similar to gabapentin — dizziness, drowsiness, blurred vision, dry mouth, weight gain, and swelling. It’s classified as a controlled substance due to its potential for misuse and dependence.
- Cymbalta (duloxetine): nausea, dry mouth, fatigue, constipation, appetite changes, and increased sweating. Stopping it abruptly can cause withdrawal-like symptoms, so any change needs to be tapered under a doctor’s guidance. It also carries interaction risks with other medications that affect serotonin.
None of this means these medications are unsafe when used as prescribed and monitored by a doctor. It does mean “just masking symptoms” isn’t a free action — there’s a real cost to staying on them long-term, which is exactly why the newest research on gabapentin is worth paying attention to.
What New Research Says About Gabapentin and Long-Term Risk
A 2025 study published in Regional Anesthesia & Pain Medicine looked at more than 1.4 million adults with chronic low back pain in a national health records database, following outcomes over a 10-year period. Researchers compared 26,416 patients who had been prescribed gabapentin six or more times against a matched group of patients who hadn’t.
The findings: patients with six or more gabapentin prescriptions had a 29% higher risk of developing dementia and an 85% higher risk of mild cognitive impairment (MCI) compared to the matched group. The risk climbed further with heavier use — patients with 12 or more prescriptions showed even higher rates than those with fewer. Perhaps most surprising, the increased risk wasn’t limited to older adults: it showed up even more strongly in younger patients, particularly those in their 30s through 60s.
A few important caveats, because we think honest information matters more than a scary headline:
- This is an association, not proof that gabapentin causes dementia. It’s a retrospective look at health records, and the study can’t fully rule out other factors — the underlying pain condition itself, other medications, or health differences between the two groups.
- The study’s own authors were careful to say this finding “warrants further investigation,” not that patients should panic or stop their medication.
- Please don’t stop or adjust a gabapentin prescription on your own based on this information. Gabapentin needs to be tapered under medical supervision — stopping abruptly can cause serious withdrawal effects, including seizures in some patients. Bring this research to your doctor and have that conversation together.
We share this not to alarm anyone, but because we think patients deserve the same information their doctors are reading — especially when it comes to a medication millions of people take for years at a time.
Where This Leaves You
If you’re currently managing peripheral neuropathy with medication alone, the honest picture is this: you’re likely getting real relief from your symptoms, and your nerves are likely still declining underneath that relief. That’s the gap our treatment approach — electroacupuncture combined with ATP Resonance BioTherapy® — is built to close. In addition to turning down the pain signal, it targets the nerve tissue itself, working to calm inflammation, improve blood flow, and support nerve regrowth.
Some patients find that as their nerve function improves, they’re able to work with their prescribing doctor to reduce their medication over time. That’s never guaranteed, and it’s never something to attempt without medical guidance — but it’s a real possibility that pure symptom management doesn’t offer.
To see what that can look like in practice, read Mary’s story: how six months of nerve-focused treatment took her from a walker and near-total numbness to walking the beach at sunrise.
We offer a free in-person consultation at AcuPoint Wellness Clinic in Vienna, VA — serving patients throughout Northern Virginia including Fairfax, Oakton, Herndon, and Reston. No pressure, no obligation. Just an honest conversation about what’s possible. If neuropathy — or the medications used to manage it — are taking pieces of your life, we’d like to help you get them back.
Call us at (703) 459-9544 or request a free consultation at acupointclinic.com.
Sources
- “Risk of dementia following gabapentin prescription in chronic low back pain patients.” Regional Anesthesia & Pain Medicine, 2025. PubMed 40639955